July 23-27, 2021 | Las Vegas, NV
2021 ASCRS Annual Meeting
GD-3 Session III: Medications and Lasers
About this Session
Session Moderators: Deborah G Ristvedt, DO, ABO,
Robert J. Noecker, MD, MBA, ABO
Presentations in this Session
-
Part 1: Medications - New Kids on the Block Part 1: New Meds
Joey Hsia, MD, ABO
-
Part 1: Medications - New Kids on the Block Part 2: New Deliveries
Ahmad A. Aref, MD, MBA, ABO
-
Part 1: Medications - Mix It up: The Role of Fixed Combination and Compounded Therapies
Roma P. Patel, MD, MBA
-
Part 2: Lasers: Is SLT First Line Therapy? - Pro: Light Trial and Other Evidence
Robert J. Noecker, MD, MBA, ABO
-
Part 2: Lasers: Is SLT First Line Therapy? - Con: Meds Should Come First
Kuldev Singh, MD, ABO
-
Part 2: Lasers: Is SLT First Line Therapy? - Case Studies
Robert J. Noecker, MD, MBA, ABO
-
Part 3: The Changing Paradigm for Glaucoma Therapy - Is There a Role for Cycloablation in Early-to-Moderate Glaucoma?
David Sola-Del Valle, MD
-
Part 3: The Changing Paradigm for Glaucoma Therapy - up in Smoke: Role of Marijuana in Glaucoma Treatment
Sameh Mosaed, MD, ABO
We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.